Lung Cancer

Braftovi Encorafenib 50 mg Capsules

Braftovi (Encorafenib 50 mg Capsules) is a prescription medication used for the treatment of certain types of cancer. Encorafenib is a kinase inhibitor that targets and inhibits the activity of the BRAF V600E mutation, which plays a role in the growth and spread of cancer cells.

Indications:

Braftovi is indicated for the treatment of:

• BRAF V600E mutation-positive unresectable or metastatic melanoma, in combination with binimetinib.
• BRAF V600E mutation-positive metastatic colorectal cancer, in combination with cetuximab, after prior therapy.

How to Use:

• Take Braftovi exactly as prescribed by your healthcare provider.
• Swallow the capsule whole with a full glass of water.
• Do not crush, chew, or open the capsule.
• Braftovi should be taken either at least 1 hour before or 2 hours after a meal.
• Follow your doctor's instructions regarding dosage and duration of treatment.

Side Effects:

Common side effects of Braftovi may include:

• Fatigue
• Nausea
• Diarrhea
• Vomiting
• Abdominal pain
• Joint pain (arthralgia)
• Rash
• Hair loss

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular monitoring may be required to manage side effects and ensure the effectiveness of the treatment.
• Use effective contraception to avoid pregnancy while taking Braftovi, as it may harm an unborn baby.
• Braftovi is not recommended for use in breastfeeding women.

Storage:

• Store Braftovi capsules at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep the capsules in their original container, tightly closed and protected from light.
• Keep out of reach of children.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.

₱0

Braftovi Encorafenib 75 mg Capsules

Braftovi (Encorafenib 75 mg Capsules) is a prescription medication used for the treatment of certain types of cancer. Encorafenib is a kinase inhibitor that works by targeting and inhibiting the activity of the BRAF V600E mutation, which is involved in the growth and spread of cancer cells.

Indications:

Braftovi is indicated for the treatment of:

• BRAF V600E or V600K mutation-positive unresectable or metastatic melanoma, in combination with binimetinib.
• BRAF V600E mutation-positive metastatic colorectal cancer, in combination with cetuximab, after prior therapy.

How to Use:

• Take Braftovi exactly as prescribed by your healthcare provider.
• Swallow the capsule whole with a full glass of water.
• Do not crush, chew, or open the capsule.
• It can be taken with or without food.
• Follow your doctor's instructions regarding dosage and duration of treatment.

Side Effects:

Common side effects of Braftovi may include:

• Fatigue
• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Arthralgia (joint pain)
• Rash
• Hair loss

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular monitoring may be required to manage side effects and ensure the effectiveness of the treatment.
• Use effective contraception to avoid pregnancy while taking Braftovi, as it may harm an unborn baby.
• Braftovi is not recommended for use in breastfeeding women.

Storage:

• Store Braftovi capsules at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep the capsules in their original container, tightly closed.
• Keep out of reach of children.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.

₱0

Afanat Afatinib 30mg Tablets

Afanat (Afatinib 30 mg Tablets) is a prescription medication used for the treatment of certain types of non-small cell lung cancer (NSCLC). Afatinib is a tyrosine kinase inhibitor that works by blocking the activity of proteins involved in the growth and spread of cancer cells.

Indications:

Afanat is indicated for the treatment of:

• First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.
• Treatment of patients with metastatic squamous NSCLC progressing after platinum-based chemotherapy.

How to Use:

• Take Afanat exactly as prescribed by your healthcare provider.
• Swallow the tablet whole with a full glass of water.
• Do not crush, chew, or break the tablet.
• It should be taken on an empty stomach, at least 1 hour before or 2 hours after eating.
• Follow your doctor's instructions regarding dosage and duration of treatment.

Side Effects:

Common side effects of Afanat may include:

• Diarrhea
• Skin rash
• Mouth sores
• Dry skin
• Nail inflammation
• Decreased appetite

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular monitoring may be required to manage side effects and ensure the effectiveness of the treatment.
• Use effective contraception to avoid pregnancy while taking Afanat, as it may harm an unborn baby.
• Afanat is not recommended for use in breastfeeding women.

Storage:

• Store Afanat tablets at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep the tablets in their original container, tightly closed.
• Keep out of reach of children.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.

₱11,648 ₱11,000

Moboxen Mobocertinib 40 mg Capsules

Moboxen (Mobocertinib 40 mg Capsules) is a prescription medication used for the treatment of specific types of non-small cell lung cancer (NSCLC). Mobocertinib is a tyrosine kinase inhibitor designed to target and inhibit the activity of epidermal growth factor receptor (EGFR) exon 20 insertion mutations, which are known to promote the growth of cancer cells.

Indications:

Moboxen is indicated for the treatment of:

• Adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations, who have received prior platinum-based chemotherapy.

How to Use:

• Take Moboxen exactly as prescribed by your healthcare provider.
• Swallow the capsule whole with a full glass of water.
• Do not crush, chew, or break the capsule.
• It can be taken with or without food.
• Follow your doctor's instructions regarding dosage and duration of treatment.

Side Effects:

Common side effects of Moboxen may include:

• Diarrhea
• Nausea
• Vomiting
• Stomatitis (inflammation of the mouth)
• Decreased appetite
• Fatigue
• Rash

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular monitoring of liver function and ECG (electrocardiogram) may be required during treatment.
• Use effective contraception to avoid pregnancy while taking Moboxen, as it may harm an unborn baby.
• Moboxen is not recommended for use in breastfeeding women.

Storage:

• Store Moboxen capsules at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep the capsules in their original container, tightly closed.
• Keep out of reach of children.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.

₱75 ₱74

ABRAXANE Injectable Suspension (Paclitaxel Protein-Bound Particles) 100mg Vail

ABRAXANE Injectable Suspension (Paclitaxel Protein-Bound Particles) 100 mg Vial is an advanced formulation of paclitaxel, a chemotherapeutic agent used to treat various types of cancer, including metastatic breast cancer, non-small cell lung cancer (NSCLC), and pancreatic cancer. Unlike traditional paclitaxel, ABRAXANE uses albumin-bound particles, which enhance the drug’s delivery to cancer cells and improve its efficacy. This formulation allows for higher concentrations of paclitaxel to be administered with a reduced risk of hypersensitivity reactions. Our super specialty pharmacy provides high-quality ABRAXANE with personalized treatment plans and expert support to ensure optimal care for cancer patients. Trust us for effective and comprehensive cancer care tailored to your needs.

₱45,000 ₱40,000

Capmaxen Capmatinib 200 mg Tablets

Capmaxen Capmatinib 200 mg Tablets is a targeted therapy used for the treatment of non-small cell lung cancer (NSCLC) with mutations leading to mesenchymal-epithelial transition (MET) exon 14 skipping. As a selective MET inhibitor, Capmatinib works by blocking the activity of the MET protein, thereby inhibiting the growth and spread of cancer cells. Our super specialty pharmacy provides high-quality Capmaxen with personalized treatment plans and expert support to ensure the best possible outcomes for patients with METex14 NSCLC. Trust us for effective cancer care and comprehensive support throughout your treatment journey.

₱0

Alkixen Crizotinib 250 mg Capsules

Alkixen Crizotinib 250 mg Capsules is a prescription medication used in the treatment of certain types of cancer. Crizotinib is a tyrosine kinase inhibitor that works by blocking abnormal proteins produced by some genes. These proteins can promote the growth of cancer cells.

Indications:

Alkixen is indicated for the treatment of:

• Non-small cell lung cancer (NSCLC) that is ALK-positive
• ROS1-positive metastatic NSCLC

How to Use:

• Take Alkixen exactly as prescribed by your healthcare provider.
• Swallow the capsule whole with a full glass of water.
• Do not crush, chew, or break the capsule.
• It can be taken with or without food.
• Follow your doctor's instructions regarding dosage and duration of treatment.

Side Effects:

Common side effects of Alkixen may include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Fatigue
• Edema (swelling)
• Vision problems (blurred vision, light sensitivity)
• Liver enzyme abnormalities

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular monitoring of liver function tests and heart function (ECG) may be required during treatment.
• Use effective contraception to avoid pregnancy while taking Alkixen, as it may harm an unborn baby.
• Alkixen is not recommended for use in breastfeeding women.

Storage:

• Store Alkixen capsules at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep the capsules in their original container, tightly closed and protected from light.
• Keep out of reach of children.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.

₱0

Alecnib Alectinib 150 mg Capsules

Alecnib (Alectinib 150 mg Capsules) is a prescription medication used for the treatment of specific types of lung cancer. Alectinib is a tyrosine kinase inhibitor that targets and blocks the activity of anaplastic lymphoma kinase (ALK), a protein that contributes to the growth and spread of cancer cells.

Indications:

Alecnib is indicated for the treatment of:

• ALK-positive, metastatic non-small cell lung cancer (NSCLC)

How to Use:

• Take Alecnib exactly as prescribed by your healthcare provider.
• Swallow the capsule whole with a full glass of water.
• Do not crush, chew, or break the capsule.
• It should be taken with food to improve absorption.
• Follow your doctor's instructions regarding the dosage and duration of treatment.

Side Effects:

Common side effects of Alecnib may include:

• Fatigue
• Constipation
• Edema (swelling) in hands and feet
• Myalgia (muscle pain)
• Cough
• Rash
• Increased liver enzymes

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular monitoring of liver function and creatine phosphokinase (CPK) levels is recommended during treatment.
• Use effective contraception to avoid pregnancy while taking Alecnib, as it may harm an unborn baby.
• Alecnib is not recommended for use in breastfeeding women.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.

₱0